PRESEPSIN (SOLUBLE CD14 SUBTYPE) LEVELS IN CIRRHOTIC PATIENTS WITH COMPENSATED OR DECOMPENSATED LIVER DISEASE WITH OR WITHOUT PORTAL HYPERTENSION RELATED BLEEDING

被引：0
|
作者：
Elefsiniotis, I. S. [1 ]
Tsakiris, S. [1 ]
Evangelidou, E. [1 ]
Barla, G. [1 ]
Tasovasili, A. [1 ]
Stathopoulou, I. [1 ]
Giannakoulopoulou, E. [1 ]
Vrachatis, D. [1 ]
Mavrogiannis, C. [1 ]
机构：
[1] Univ Athens, Gen & Oncol Hosp Kifisia Agioi Anargyroi, Internal Med Hepatogastroenterol, Athens, Greece
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01239-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-018
引用
收藏
页码：S659 / S660
页数：2
相关论文
共 50 条
  • [31] Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension
    Pastrovic, Frane
    Novak, Rudjer
    Grgurevic, Ivica
    Hrkac, Stela
    Salai, Grgur
    Zarak, Marko
    Grgurevic, Lovorka
    PLOS ONE, 2024, 19 (04):
  • [32] Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial
    Serge Masson
    Pietro Caironi
    Caterina Fanizza
    Ralf Thomae
    Roberto Bernasconi
    Andrea Noto
    Roberto Oggioni
    Giovanni Stefano Pasetti
    Marilena Romero
    Gianni Tognoni
    Roberto Latini
    Luciano Gattinoni
    Intensive Care Medicine, 2015, 41 : 1736 - 1736
  • [33] Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure
    Ishii, J.
    Nishimura, G.
    Takahashi, H.
    Kawai, H.
    Muramatsu, T.
    Harada, M.
    Motoyama, S.
    Naruse, H.
    Watanabe, E.
    Hayashi, M.
    Izawa, H.
    Ozaki, Y.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1038 - 1038
  • [34] Presepsin ( soluble CD14 subtype) Is Secreted from Human Monocytes after Phagocytosis - in Vitro Analyses and a Retrospective Cohort Study in Patients with Allogeneic Stem Cell Transplantation
    Arai, Yasuyuki
    Yamashita, Kouhei
    Mizugishi, Kiyomi
    Takaori-Kondo, Akifumi
    BLOOD, 2014, 124 (21)
  • [35] Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease
    Lin, B
    Noring, R
    Steere, AC
    Klempner, MS
    Hu, LT
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03): : 1185 - 1188
  • [36] Soluble CD163 plasma concentration is related with necroinflammatory activity and liver function impairment in compensated cirrhotic patients and is not related with bacterial translocation
    Figorilli, Francesco
    Thomsen, Karen Louise
    MacNaughtan, Jane
    Cox, I. Jane
    Moratalla, Alba
    Ranchal, Isidora
    Moller, Holger J.
    Mookerjee, Rajeshwar
    Davies, Nathan
    Jalan, Rajiv
    HEPATOLOGY, 2015, 62 : 850A - 851A
  • [37] Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
    Gronbaek, H.
    Sandahl, T. D.
    Mortensen, C.
    Vilstrup, H.
    Moller, H. J.
    Moller, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (02) : 173 - 180
  • [38] Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease
    Hosomi, Shuhei
    Yamagami, Hirokazu
    Itani, Shigehiro
    Yukawa, Tomomi
    Otani, Koji
    Nagami, Yasuaki
    Tanaka, Fumio
    Taira, Koichi
    Kamata, Noriko
    Tanigawa, Tetsuya
    Shiba, Masatsugu
    Watanabe, Toshio
    Fujiwara, Yasuhiro
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (01): : 87 - 95
  • [39] Serum levels of soluble CD14 correlate with disease activity in multiple sclerosis patients and are increased by interferon-beta treatment
    Lutterotti, A.
    Kuenz, B.
    Khalil, M.
    Gredler, V.
    Ehling, R.
    Gneiss, C.
    Deisenhammer, F.
    Berger, T.
    Reindl, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S66 - S66
  • [40] SERUM SEPSIS MARKERS SOLUBLE CD14 SUBTYPE AND SOLUBLE IL2 RECEPTOR AS POTENTIAL BIOMARKERS FOR COMPLETE MUCOSAL HEALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hosomi, Shuhei
    Yamagami, Hirokazu
    Itani, Shigehiro
    Watanabe, Kimihiko
    Hirata, Naoto
    Yukawa, Tomomi
    Otani, Koji
    Nagami, Yasuaki
    Tanaka, Fumio
    Taira, Koichi
    Kamata, Noriko
    Tanigawa, Tetsuya
    Shiba, Masatsugu
    Watanabe, Toshio
    Fujiwara, Yasuhiro
    GASTROENTEROLOGY, 2017, 152 (05) : S777 - S777
12345